Miguel Pereira-Silva, Postdoctoral Scientist at MD Anderson Cancer Center, shared a post on LinkedIn:
“For anyone working in cancer biology, tumor microenvironment research, or translational oncology, this piece provides a concise yet powerful perspective on where the field is heading.
The authors highlight how complex interactions between malignant and stromal cell types of shape, tumor progression, resistance to therapy, and immune suppression in pancreatic cancer — a disease long known for its poor prognosis and therapeutic challenges.”
Other OncoDaily articles featuring Miguel Pereira-Silva.